MICHELLE SNODGRASS: Open Payments
NPI 1154693091 · KINGSPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 54 payments from 14 companies in 2025. Trend: 2023 $730 · 2024 $660 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $196 |
| ABBVIE INC. | 14 | $159 |
| PFIZER INC. | 4 | $68 |
| GlaxoSmithKline, LLC. | 4 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Lilly USA, LLC | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: Ozempic, VRAYLAR, UBRELVY, TRELEGY ELLIPTA, LEQVIO, ELIQUIS, JARDIANCE, NURTEC ODT.
Industry payments across TN — which companies pay providers there.
